Fenretinide, Synthetic retinoid agonist

Be the first to review this product! 리뷰 제출

|

(0 출판물)

MW 391.5 Da, Purity >99%. Synthetic retinoid agonist. Anticancer, apoptotic, antioxidant activity in vitro and in vivo. Demonstrates a long half-life in vivo.

대체 명칭 보기

1,8-cineole 2-exo-monooxygenase, 3-dioxygenase 2, 3-dioxygenase-like protein 1, A830040C14Rik, ACEE, ACES_HUMAN, ACLS, AHDC, AI838772, AIS, ALDC, ALDH 1, ALDH 11, ALDH class 1, ALDH class 2, ALDH-E1, ALDH-E2, ALDHI, ALDM, ALHDII, ANDR_HUMAN, APOPAIN, AR, AR8, ARACHE, ARO, ARO1, AW493413, Acetaldehyde dehydrogenase 1, Acetaldehyde dehydrogenase 2, Acetylcholinesterase, Albendazole monooxygenase, Albendazole sulfoxidase, Aldehyde dehydrogenase 1, Aldehyde dehydrogenase 1 family member A1, Aldehyde dehydrogenase 1 soluble, Aldehyde dehydrogenase 1A1, Aldehyde dehydrogenase 2 family, Aldehyde dehydrogenase 2 family (mitochondrial), Aldehyde dehydrogenase cytosolic, Aldehyde dehydrogenase liver cytosolic, Aldehyde dehydrogenase mitochondrial, Aldh, Androgen nuclear receptor variant 2, Androgen receptor, Androgen receptor (dihydrotestosterone receptor, testicular feminization, spinal and bulbar muscular atrophy, Kennedy disease), Antigen NY-CO-13, Apoptosis related acetylcholinesterase, Apoptotic protease Mch-3, Aromatase, Atherosclerosis, susceptibility to, included, BCC7, BXR, C-mpl ligand, CASP3_HUMAN, CASP7_HUMAN, CBX, CBX1_HUMAN, CC3, CMH-1, CMT1A, CMT1E, CP19A_HUMAN, CP33, CP34, CP3A4_HUMAN, CPP-32, CPP32B, CPV1, CRBP, CRBP-I, CRBP1, CRBP2, CYAR, CYP19, CYP3, CYP3A, CYP3A3, CYP3A4, CYPIIIA3, CYPIIIA4, CYPXIX, Casp3a, Caspase 3, apoptosis-related cysteine peptidase, Caspase 3, apoptosis-related cysteine protease, Caspase 3, apoptosis-related cysteine protease a, Caspase 7, Caspase 7 apoptosis related cysteine peptidase, Caspase-3, Caspase-3 subunit p12, Caspase-7 subunit p11, Cellular retinol-binding protein, Cellular retinol-binding protein I, Cellular tumor antigen p53, Chromobox 1, Chromobox homolog 1 (HP1 beta homolog Drosophila ), Chromobox protein homolog 1, Cyp19a1, Cysteine protease CPP32, Cytochrome P-450AROM, Cytochrome P450 19A1, Cytochrome P450 3A3, Cytochrome P450 3A4, Cytochrome P450 HLp, Cytochrome P450 NF-25, Cytochrome P450 family 3 subfamily A polypeptide 4, Cytochrome P450 subfamily IIIA polypeptide 4, Cytochrome P450, family 19, subfamily A, polypeptide 1, Cytochrome P450, subfamily XIX (aromatization of androgens), Cytochrome P450-PCN1, Cytosolic NADP-isocitrate dehydrogenase, DHTR, DKFZp686N23123, DNA binding protein, Dihydro testosterone receptor, Dihydrotestosterone receptor (DHTR), Drosophila HP1 beta, EC 1.13.11., EC 3.4.22.56, ER, ER-alpha, ER-beta, ERR a, ERR-alpha, ERR1 protein, ERR1_HUMAN, ER[a], ER[b], ESR, ESR B, ESR BETA, ESR1_HUMAN, ESRA, ESRL 1, ESRR A, ESTR B, Epididymis luminal protein 216, Epididymis secretory protein Li 26, Era, Erb, Erb2, Estr, Estra, Estradiol Receptor alpha, Estradiol Receptor beta, Estradiol receptor, Estrogen Receptor 1, Estrogen Receptor 2, Estrogen receptor, Estrogen receptor 1 (alpha), Estrogen receptor 2 (ER beta), Estrogen receptor 2 ER beta, Estrogen receptor alpha, Estrogen receptor beta 4, Estrogen receptor related 1, Estrogen receptor-like 1, Estrogen resistance, included, Estrogen synthase, Estrogen synthetase, Estrogen-related receptor alpha, Estrra, FK506 binding protein 12 rapamycin associated protein 1, FK506 binding protein 12 rapamycin associated protein 2, FK506-binding protein 12-rapamycin complex-associated protein 1, FKBP rapamycin associated protein, FKBP12-rapamycin complex-associated protein, FKBP12-rapamycin complex-associated protein 1, FLJ11090, FLJ44809, FLJ92943, FRAP, FRAP1, FRAP2, GAS-3, GCPS, GLI Kruppel family member GLI 3, GLI Kruppel family member GLI3 (Greig cephalopolysyndactyly syndrome), GLI family zinc finger 3, GLI3 C-terminally truncated form, GLI3 form of 190 kDa, GLI3 form of 83 kDa, GLI3 full length protein, GLI3-190, GLI3-83, GLI3FL, GLI3_HUMAN, Glioma associated oncogene family zinc finger 3, Glucocorticoid inducible P450, Growth Arrest Specific 3, Growth arrest-specific protein 3, HD 7, HD 7B, HD 9, HDAC, HDAC 7B, HDAC 9B, HDAC 9FL, HDAC9_HUMAN, HDL cholesterol, augmented response of, to hormone replacement, included, HDRP, HEL-216, HEL-S-26, HLP, HMSNIA, HNPP, HP1 beta, HP1 beta homolog, HP1 beta homolog Drosophila, HP1, Drosophila. homolog of, beta, HP1Hs beta, HUMARA, HYSP1, Heterochromatin protein 1 beta, Heterochromatin protein 1 homolog beta, Heterochromatin protein p25, Histone deacetylase 4/5 related protein, Histone deacetylase 7, Histone deacetylase 7B, Histone deacetylase 9, Histone deacetylase 9A, Histone deacetylase-related protein, Human heterochromatin protein p25 mRNA complete cds, I23O2_HUMAN, ICDH, ICE-LAP3, ICE-like apoptotic protease 3, ICE3, IDCD, IDH, IDH1, IDHC_HUMAN, IDO-2, IDP, IDPC, IMD42, INDOL 1, Indoleamine 2, Indoleamine 2,3 dioxygenase 2, Indoleamine 2,3 dioxygenase like 1 protein, Indoleamine 2,3 dioxygenase like protein 1, Indoleamine pyrrole 2,3 dioxygenase like 1, Indoleamine pyrrole 2,3 dioxygenase like protein 1, Indoleamine-pyrrole 2, Isocitrate dehydrogenase (NADP(+)) 1 cytosolic, Isocitrate dehydrogenase 1 (NADP+) soluble, Isocitrate dehydrogenase [NADP] cytoplasmic, KD, KIAA0744, Kennedy disease (KD), LFS1, LICE, LICE2, Liver mitochondrial ALDH, M31, MCH3, MEF2 interacting transcription repressor protein, MEF2-interacting transcription repressor MITR, MGC104252, MGC104309, MGC112732, MGC126680, MGC129539, MGC1806, MGC20769, MGC2318, MGDF, MITR, MKCSF, MOD 1, MPL ligand, MPLLG, MTOR_HUMAN, Mammalian target of rapamycin, Mechanistic target of rapamycin, Megakaryocyte colony-stimulating factor, Megakaryocyte growth and development factor, Megakaryocyte stimulating factor, Microsomal monooxygenase, Mitochondrial aldehyde dehydrogenase 2, Modifier 1 protein, Mutant tumor protein 53, Myeloproliferative leukemia virus oncogene ligand, Myocardial infarction, susceptibility to, included, N-ACHE, NADP dependent isocitrate dehydrogenase cytosolic, NADP dependent isocitrate dehydrogenase peroxisomal, NADP(+)-specific ICDH, NF 25, NR1B1, NR1C3, NR1F3, NR1I2_HUMAN, NR3A1, NR3A2, NR3B1, NR3C4, Nifedipine oxidase, Nuclear mitotic apparatus protein retinoic acid receptor alpha fusion protein, Nuclear receptor ROR-gamma, Nuclear receptor RZR-gamma, Nuclear receptor subfamily 1 group B member 1, Nuclear receptor subfamily 1 group C member 3, Nuclear receptor subfamily 1 group F member 3, Nuclear receptor subfamily 1 group I member 2, Nuclear receptor subfamily 3 group A member 1, Nuclear receptor subfamily 3 group A member 2, Nuclear receptor subfamily 3 group B member 1, Nuclear receptor subfamily 3 group C member 4, Nuclear receptor subfamily 3 group C member 4 (NR3C4), Nucleophosmin retinoic acid receptor alpha fusion protein NPM RAR long form, Nucleus encoded mitochondrial aldehyde dehydrogenase 2, ONR 1, OTTHUMP00000001983, OTTHUMP00000017718, OTTHUMP00000017719, OTTHUMP00000162543, OTTHUMP00000165052, OTTHUMP00000165053, OTTHUMP00000165054, OTTHUMP00000198350, OTTHUMP00000215173, OTTHUMP00000215174, OTTHUMP00000215175, Oncogene GLI3, Orphan nuclear receptor PAR 1, Orphan nuclear receptor PXR, Oxalosuccinate decarboxylase, P 450AROM, P450 III steroid inducible, P450 PCN1, P450, family III, P450C3, P53_HUMAN, PAP A, PAPB, PAR, PAR q, PARP cleavage protease, PICD, PMP22_HUMAN, PPAR-gamma, PPARG2, PPARG_HUMAN, PPD IV, PRR, PUMB 1, Peripheral myelin protein 22, Peroxisome proliferator activated receptor gamma 2, Peroxisome proliferator-activated receptor gamma, Phosphoprotein p53, Pregnane X receptor, Procaspase3, Protein Yama, Quinine 3-monooxygenase, RAFT1, RALDH 1, RAPT1, RAR, RAR related orphan nuclear receptor variant 2, RAR related orphan receptor C, isoform a, RAR related orphan receptor gamma, RAR-alpha, RAR-related orphan receptor C, RARA_HUMAN, RARalpha1, RBPC, RET1_HUMAN, RNESTROR, RORG_HUMAN, RP24-311F12.2, RZR GAMMA, RZRG, Rapamycin and FKBP12 target 1, Rapamycin associated protein FRAP2, Rapamycin target protein, Rapamycin target protein 1, Retinal dehydrogenase 1, Retinaldehyde dehydrogenase 1, Retinoic acid binding receptor gamma, Retinoic acid nuclear receptor alpha variant 1, Retinoic acid nuclear receptor alpha variant 2, Retinoic acid receptor alpha, Retinoic acid receptor alpha polypeptide, Retinoid-related orphan receptor-gamma, Retinol binding protein 1 cellular, Retinol binding protein 2 cellular, Retinol binding protein 4 plasma, Retinol-binding protein 1, Rorc, SBMA, SCA-1, SCAN1, SMAX1, SREBP cleavage activity 1, SXR, Serine/threonine-protein kinase mTOR, Spinal and bulbar muscular atrophy, Spinal and bulbar muscular atrophy (SBMA), Steroid and xenobiotic receptor, Steroid hormone receptor ERR1, TFM, THCYT1, TOR, TRP53, TYDP, TYDP1_HUMAN, Taurochenodeoxycholate 6-alpha-hydroxylase, Testicular Feminization (TFM), Thrombopoietin, Thrombopoietin nirs variant 1, Tp53, Transcriptional activator GLI3, Transcriptional repressor GLI3R, Transformation related protein 53, Trembler, Tumor protein 53, Tumor protein p53, Tumor suppressor p53, Tyr-DNA phosphodiesterase 1, Tyrosyl-DNA phosphodiesterase 1, YT, YT blood group, Yama, Yama protein, Zinc finger protein GLI 3, androgen receptor splice variant 4b, chromobox homolog 1, cytochrome P450, subfamily IIIA (niphedipine oxidase), polypeptide 3, cytochrome P450, subfamily IIIA (niphedipine oxidase), polypeptide 4, dJ576K7.1 (FK506 binding protein 12 rapamycin associated protein 1), estrogen receptor related receptor alpha, flavoprotein-linked monooxygenase, hERR1, heterochromatin protein p25 beta, mldy, p25beta, p53 tumor suppressor, pregnane X nuclear receptor variant 2, tumor antigen p55